[Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
D000284:Administration, Oral; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008454:Mazindol / Q000009:adverse effects / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy*; D010919:Placebos; D012119:Respiration / Q000187:drug effects; D014987:Xerostomia / Q000139:chemically induced
D007211:Indoles; D010919:Placebos; D008454:Mazindol
Tratamiento de la obesidad con un anorexígeno no anfetamínico.